| 000 | 00955 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513133613.0 | ||
| 264 | 0 | _c19980204 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStein, K | |
| 245 | 0 | 0 |
_aAdvertisements for donepezil. BMJ should require advertisements to detail actual state of evidence. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cDec 1997 |
||
| 300 |
_a1623-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment | ||
| 650 | 0 | 4 |
_aAdvertising _xstandards |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aDonepezil |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndans _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperidines _xtherapeutic use |
| 700 | 1 | _aMilne, R | |
| 700 | 1 | _aBest, L | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 315 _gno. 7122 _gp. 1623-4 |
|
| 999 |
_c9406608 _d9406608 |
||